Why e.l.f. Beauty Stock Should Turnaround After A Weak January (NYSE:ELF)

1 min read
1 views

This article was written by

I like following medical device stocks. My investments are Stereotaxis, Delcath, AVITA Medical, & e.l.f. I’m short Palantir.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ELF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I have a 2.5% position in e.l.f. Beauty

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

What would be the impact of a credit card interest rate cap?

Latest from News